Mucommune, LLC

NIH SBIR/STTR award: IND-enabling development of MM012, an antibody-based non-hormonal contraceptive intravaginal ring

USD 1,163,587.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: SBIR: In vivo engineering of dual CD19/CD138 CAR-T cells for treatment of Systemic Lupus Erythematosus

USD 1,006,467.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: SBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma

USD 1,146,083.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: SBIR: In vivo engineering of multifaceted B7H3.CAR-T cells for cellular immunotherapy of pancreatic ductal adenocarcinoma

USD 1,146,618.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Fast Dissolving MM008 Tablet for Instant On-Demand Non-Hormonal Contraception

USD 1,168,977.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development and evaluation of a pegloticase biobetter for sustained suppressionof fructose-induced obesity

USD 359,608.00 · National Institute of Diabetes and Digestive and Kidney Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Fast Dissolving MM008 Tablet for Instant On-Demand Non-Hormonal Contraception

USD 1,130,880.00 · Eunice Kennedy Shriver National Institute of Child Health and Human Development · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Development of MM010, a PEG-specific intervention that blocks allergic response and restores effective repeat dosing of peg-asparaginase in patients with acute lymphoblastic leukemia

USD 409,732.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy

USD 1,025,819.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: SBIR: In vivo engineering of B7-H3.CAR-T cells for ovarian cancer therapy

USD 1,031,566.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Engineering a physiologically-tuned reservoir intravaginal ring releasing lactic acid for the treatment and prevention of bacterial vaginosis

USD 309,210.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: Engineering a physiologically-tuned reservoir intravaginal ring releasing lactic acid for the treatment and prevention of bacterial vaginosis

USD 310,136.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis

USD 992,780.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: IND-enabling development of MM-009, a reservoir-intravaginal ring for ultra-highrates of month-long lactic acid release to treat and prevent bacterial vaginosis

USD 1,025,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)

NIH SBIR/STTR award: IND-enabling development of MM010, a PEG-specific intervention that blocks allergic response and restores repeated dosing for select PEGylated medicines impacted by anti-PEG antibody

USD 291,458.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)